The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
Open accessAbstract
The interferon-induced enzymes 2'-5'-oligoadenylate synthetase (OAS) and RNase L are key components of innate immunity involved in sensory and effector functions following viral infections. Upon binding target RNA, OAS is activated to produce 2'-5'-linked oligoadenylates (2-5A) that activate RNase L, which then cleaves single-stranded self and non-self RNA. Modified nucleosides that are present in cellular transcripts have been shown to suppress activation of several RNA sensors. Here, we demonstrate that in vitro transcribed, unmodified RNA activates OAS, induces RNase L-mediated ribosomal RNA (rRNA) cleavage and is rapidly cleaved by RNase L. In contrast, RNA containing modified nucleosides activates OAS less efficiently and induces limited rRNA cleavage. Nucleoside modifications also make RNA resistant to cleavage by RNase L. Examining translation in RNase L(-/-) cells and mice confirmed that RNase L activity reduces translation of unmodified mRNA, which is not observed with modified mRNA. Additionally, mRNA containing the nucleoside modification pseudouridine is translated longer and has an extended half-life. The observation that modified nucleosides in RNA reduce 2-5A pathway activation joins OAS and RNase L to the list of RNA sensors and effectors whose functions are limited when RNA is modified, confirming the role of nucleoside modifications in suppressing immune recognition of RNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Cleavage of Ψ-containing RNA by RNase L. Purified RNase L was activated on ice by trimer 2-5A prior to mixing with RNA substrates. (A) Cleavage of oligo RNAs [32P]pC11U2C7 (UU) or [32P]pC11Ψ2C7 (ΨΨ) by RNase L. Reactions were stopped at the indicated time by addition of loading buffer, and reactions were separated by PAGE and visualized by phosphor-storage radiography. Representative data from one of three independent experiments is shown. (B) Quantification of band intensities. Values were normalized to the values obtained in the 30 min reaction not containing RNase L. Data represents average ± SEM of n = 3 experiments. Asterisks indicate P < 0.05. (C) Cleavage of metabolically [32P]-labeled unmodified (U) or Ψ-containing firefly luciferase mRNA by RNase L. Reactions were stopped at indicated times. Aliquots of isolated RNA from each reaction were separated by PAGE and visualized by phosphor-storage radiography. Representative data from one of three independent experiments is shown.](/paper-figures/3e70e86db969446294caf16a731711d6/nucleoside-modifications-in-rna-limit-activation-of-2-5-oligoadenylate-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Transferring this concept to in vitro transcribed mRNA, for instance, pseudouridine-containing mRNAs reduced activation of known RNA sensors substantially.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, nucleoside modifications are well known to limit or even inhibit RNA sensor engagement.20,21,22”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [21]
In the citing paper
“Nucleoside-modified mRNA can reduce the activation of TLRs, retinoic acid-inducible gene I (RIG-I), protein kinase R (PKR), and 2′-5′-oligoadenylate synthetase (OAS). Additionally, nucleoside modification increases translation activity and resistance against RNase L-mediated degradation.54,81,173–176”
From Advances in COVID-19 mRNA vaccine development (2022) · cites this paper as [175]
In the citing paper
“These alterations possibly lead to a blunted specific immune response.37,133, 134, 135”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [135]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Self-citationmRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Self-citation2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
Daffis, S., Szretter, K. J., Schriewer, J. M., Li, J., Youn, S., Errett, J. S., Lin, T., Schneller, S. W., Züst, R., Dong, H., et al. (2010) · Nature · doi:10.1038/nature09489 · Cited by 910
Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B. W., Ziebuhr, J., Szretter, K. J., Baker, S. C., Barchet, W., Diamond, M. S., et al. (2011) · Nature Immunology · doi:10.1038/ni.1979 · Cited by 811
Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation
Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682
Self-citationSmall self-RNA generated by RNase L amplifies antiviral innate immunity
Malathi, K., Dong, B., Gale, M., & Silverman, R. H. (2007) · Nature · doi:10.1038/nature06042 · Cited by 663
Modification and Editing of RNA
Auffinger, P., Grosjean, H., & Benne, R. (1998) · ASM Press eBooks · doi:10.1128/9781555818296 · Cited by 643
Pseudouridine in RNA: What, Where, How, and Why
Charette, M., & Gray, M. W. (2000) · IUBMB Life · doi:10.1080/152165400410182 · Cited by 577
Zhou, A., Paranjape, J., Brown, T. L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, B., Fairchild, R., Colmenares, C., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6355 · Cited by 559
The RNA Modification Database: 1999 update
Rozenski, J., Crain, P. F., & McCloskey, J. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.196 · Cited by 390
Sayan, B. S. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401459 · Cited by 389
Interferon Action: RNA Cleavage Pattern of a (2′-5′)Oligoadenylate—Dependent Endonuclease
Floyd-Smith, G., Slattery, E., & Lengyel, P. (1981) · Science · doi:10.1126/science.6165080 · Cited by 362
New Insights into the Role of RNase L in Innate Immunity
Chakrabarti, A., Jha, B. K., & Silverman, R. H. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0120 · Cited by 326
Interferon action—sequence specificity of the ppp(A2′p)nA-dependent ribonuclease
Wreschner, D. H., McCauley, J. W., Skehel, J. J., & Kerr, I. M. (1981) · Nature · doi:10.1038/289414a0 · Cited by 321
Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
Liao, J., Yu, L., Mei, Y., Guarnera, M., Shen, J., Li, R., Liu, Z., & Jiang, F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-198 · Cited by 293
Fine-Tuning of RNA Functions by Modification and Editing
Grosjean, H. (2005) · Topics in current genetics · doi:10.1007/b95147 · Cited by 289
A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A System
Castelli, J. C., Hassel, B. A., Wood, K. A., Li, X., Amemiya, K., Dalakas, M. C., Torrence, P. F., & Youle, R. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.967 · Cited by 270
Minks, M. A., West, D. K., Benvin, S., & Baglioni, C. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86690-5 · Cited by 258
Ribosomal RNA cleavage, nuclease activation and 2-5A (ppp(A2′p)nA) in interferon-treated cells
Wreschner, D. H., James, T. C., Silverman, R. H., & Kerr, I. M. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.7.1571 · Cited by 245
Crain, P. F., & McCloskey, J. A. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.126 · Cited by 200
Hartmann, R., Justesen, J., Sarkar, S. N., Sen, G. C., & Yee, V. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00433-7 · Cited by 182
Mechanism for discrimination between viral and host mRNA in interferon-treated cells.
Nilsen, T. W., & Baglioni, C. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.6.2600 · Cited by 160
Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase.
Dong, B., Xu, L., Zhou, A., Hassel, B. A., Lee, X., Torrence, P. F., & Silverman, R. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36767-4 · Cited by 157
Nallagatla, S. R., & Bevilacqua, P. C. (2008) · RNA · doi:10.1261/rna.1007408 · Cited by 143
RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP
Malathi, K., Saito, T., Crochet, N., Barton, D. J., Gale, M., & Silverman, R. H. (2010) · RNA · doi:10.1261/rna.2244210 · Cited by 136
Small-molecule activators of RNase L with broad-spectrum antiviral activity
Thakur, C. S., Jha, B. K., Dong, B., Gupta, J. D., Silverman, K. M., Mao, H., Sawai, H., Nakamura, A., Banerjee, A. K., Gudkov, A. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700590104 · Cited by 131
Gallie, D., Tanguay, R. L., & Leathers, V. L. (1995) · Gene · doi:10.1016/0378-1119(95)00521-7 · Cited by 125
Li, X., Blackford, J. A., & Hassel, B. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2752-2759.1998 · Cited by 121
Malathi, K., Paranjape, J. M., Bulanova, E., Shim, M., Guenther-Johnson, J. M., Faber, P. W., Eling, T. E., Williams, B. R. G., & Silverman, R. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507551102 · Cited by 108
Detection and quantitation of RNA base modifications
Zhao, X., & Yu, Y. (2004) · RNA · doi:10.1261/rna.7110804 · Cited by 93
The biosynthesis and functional roles of methylated nucleosides in eukaryotic mRNA
Bokar, J. A. (2005) · Topics in current genetics · doi:10.1007/b106365 · Cited by 93
Activation of 2′-5′ Oligoadenylate Synthetase by Single-stranded and Double-stranded RNA Aptamers
Hartmann, R., Nørby, P. L., Martensen, P. M., Jørgensen, P., James, M. C., Jacobsen, C. B., Moestrup, S. K., Clemens, M. J., & Justesen, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3236 · Cited by 87
Enzymatic Characteristics of Recombinant Medium Isozyme of 2′-5′ Oligoadenylate Synthetase
Sarkar, S. N., Bandyopadhyay, S., Ghosh, A., & Sen, G. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1848 · Cited by 70
Activation of Interferon-inducible 2′ −5′ Oligoadenylate Synthetase by Adenoviral VAI RNA
Desai, S. Y., Patel, R. C., Sen, G. C., Malhotra, P., Ghadge, G. D., & Thimmapaya, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3454 · Cited by 66
The Evolution of the IUBMB-Nicholson Maps
Nicholson, D. E. (2000) · IUBMB Life · doi:10.1080/152165400300089295 · Cited by 65
Cleavage of Oligoribonucleotides by the 2′,5′-Oligoadenylate- dependent Ribonuclease L
Carroll, S. S., Chen, E., Viscount, T., Geib, J., Sardana, M. K., Gehman, J. D., & Kuo, L. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4988 · Cited by 61
Molinaro, R. J., Jha, B. K., Malathi, K., Varambally, S., Chinnaiyan, A. M., & Silverman, R. H. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl968 · Cited by 59
Advances in Enzymology and Related Areas of Molecular Biology
(1992) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123119 · Cited by 56
Elbahesh, H., Jha, B. K., Silverman, R. H., Scherbik, S. V., & Brinton, M. A. (2010) · Virology · doi:10.1016/j.virol.2010.10.016 · Cited by 53
Naylor, R. N., Ho, N. W. Y., & Gilham, P. T. (1965) · Journal of the American Chemical Society · doi:10.1021/ja01096a050 · Cited by 53
Properties of pseudouridine N1 imino protons located in the major groove of an A-form RNA duplex
Hall, K. B., & McLaughlin, L. W. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.8.1883 · Cited by 49
Nilsen, T. W., Maroney, P. A., Robertson, H. D., & Baglioni, C. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.2.154 · Cited by 48
2′-5′-Oligoadenylate synthetase is activated by a specific RNA sequence motif
Kodym, R., Kodym, E., & Story, M. D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.167 · Cited by 48
Minks, M. A., West, D. K., Benvin, S., Greene, J. J., Ts’o, P. O. P., & Baglioni, C. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43752-0 · Cited by 46
Baglioni, C., Benedetti, A. D., & Williams, G. J. (1984) · Journal of Virology · doi:10.1128/jvi.52.3.865-871.1984 · Cited by 44
Sharp, T. V., Raine, D. A., Gewert, D. R., Joshi, B., Jagus, R., & Clemens, M. J. (1999) · Virology · doi:10.1006/viro.1999.9689 · Cited by 41
Thakur, C. S., Xu, Z., Wang, Z., Novince, Z., & Silverman, R. H. (2005) · Humana Press eBooks · doi:10.1385/1-59259-939-7:103 · Cited by 40
Baglioni, C., Minks, M. A., & Clercq, E. D. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.19.4939 · Cited by 37
Activation of human and mouse 2‐5A synthetases and mouse protein P1 kinase by nucleic acids
Torrence, P. F., Johnston, M. I., EPSTEIN, D. A., Jacobsen, H., & Friedman, R. M. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)81142-8 · Cited by 26
Narayan, P., & ROTTMAN, F. M. (1992) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123119.ch7 · Cited by 25
Mordechai, E., Kon, N., Henderson, E. E., & Suhadolnik, R. J. (1995) · Virology · doi:10.1006/viro.1995.1014 · Cited by 24
Ueno, Y., Yamada, Y., Nakanishi, M., & Kitade, Y. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.08.025 · Cited by 6
Research works printed but not linked: 2
- 2005, 23, 165
- 1995, 165, 233
Cited by
Sorted by citations
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
Self-citationTherapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Modified mRNA vaccines protect against zika virus infection
Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909
Metadata
- Authors
- Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K.
- Affiliations
- University of Pennsylvania (US)
- Cleveland Clinic (US)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-08-03
- Volume
- 39
- Issue
- 21
- Pages
- 9329-9338
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3241635
- OpenAlex
- W2071136305
- Cited by
- 356
- References
- 54
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 39 · 2023: 49 · 2022: 43 · 2021: 51 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 13 · 2016: 6 · 2015: 12 · 2014: 6 · 2013: 7 · 2012: 9
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (T32 GM- 07229)
- National Heart, Lung, and Blood Institute (R42HL087688, R42HL87688)
- National Cancer Institute (R01CA044059)
- National Institute of General Medical Sciences (T32GM007229, T32GM07229)
- National Institute of Allergy and Infectious Diseases (R01 AI50484, R01AI050484)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007748, T32 DK-07748)
- National Institute of Neurological Disorders and Stroke (R01NS029331)
- National Institute of Dental and Craniofacial Research (R21DE019059)
- National Center for Research Resources (T32RR007063)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- nucleoside modification, RNA, 2',5'-oligoadenylate synthetase, RNase L, pseudouridine, mRNA translation, mRNA stability, RNA sensors, innate immunity, interferon signaling, viral RNA sensing, immune evasion
- MeSH terms
- Animals, Cells, Cultured, Endoribonucleases, Half-Life, Humans, Nucleosides, Pseudouridine, RNA, RNA, Ribosomal, Protein Biosynthesis, Uridine, 2',5'-Oligoadenylate Synthetase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review